Navigation Links
HIV Prevalence In Ethiopian Women Greater Than National Average

Ethiopian Health Minister Dr Kebede Worku has said that there has been a significant jump in HIV/AIDS infection among women in the country. The prevalence rate is 5 percent//.

'Women are vulnerable to the HIV/Aids pandemic due to their low socio-economic status in Ethiopia, on top of their biological factors,' he said. 'The national surveillance report estimates the HIV prevalence among women in the country to be 5 percent.' He was speaking at the annual conference of the Ethiopian Medical Association.

A senior AIDS official said that the rate of infections in women was higher than the national average of 4.4 percent. 'The 5% HIV/Aids prevalence among women is bad news, since it shows that there is still a lot that needs to be done in preventing the spread of the disease among women,' he said. 'This is a wake-up call to the government and others working to curtail the spread of HIV/Aids.'

The minister said that a free anti-retroviral treatment (ART) program had been launched in January 2005 and around 35,000 people had benefited from it so far.


'"/>




Page: 1

Related medicine news :

1. High Prevalence of AIDS among Indian Truck drivers
2. Survey Reveals Alarming Prevalence Rates of Diabetes among US Adolescents
3. Prevalence Of AIDS Goes Down In Illinois
4. HIV Prevalence in South Africa May be on Decline
5. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
6. Prevalence of Celiac disease in children with type 1 diabetes
7. Prevalence of AIDS Cases in UAE is Low
8. Thailand Approves Strategic Plan To Reduce HIV Prevalence Among Youth
9. Scientists Find Clue for the Prevalence of Bladder Cancer More in Men
10. Ethiopian Children Face Threat From Malnutrition
11. Women suffer from sexual dysfunction too
Post Your Comments:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 1Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 2Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 3Clues to Hypertension in Kids May Be Seen in Bones 59798 1Clues to Hypertension in Kids May Be Seen in Bones 59798 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3
Other Medicine Technology:Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6